Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
BMAL2
gene encodes a member of the basic helix-loop-helix PER-ARNT-SIM family of transcription factors, which control diverse physiological processes including circadian rhythms. We identified four novel human
BMAL2
transcripts that differ by alternative splicing within their NH2-terminal regions. Divergent expression of these and previously reported transcripts was observed among human tissues. The functional consequences of alternative splicing for transcriptional activation by CLOCK:
BMAL2
heterodimers were assessed using luciferase reporter gene constructs that contained one of three diurnally regulated promoters, namely, those of the mouse period1, mouse
vasopressin
, and human plasminogen activator inhibitor-1 genes. These studies revealed that alternative splicing generates
BMAL2
isoforms possessing high, medium, low, or no transcriptional activity. Similar results were obtained with each promoter, suggesting that alternative splicing may influence the amplitudes of both central and peripheral oscillators. Indeed, alternative splicing of
BMAL2
may provide tissues with a rheostat capable of regulating CLOCK:
BMAL2
heterodimer function across a broad continuum of potential transcriptional activities to accommodate varied metabolic demands and physiological roles.
...
PMID:Alternative splicing yields novel BMAL2 variants: tissue distribution and functional characterization. 1205 78